A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies Read more about A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies
A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS) Read more about A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)
Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer Read more about Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors Read more about Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
[Trial of device that is not approved or cleared by the U.S. FDA] Read more about [Trial of device that is not approved or cleared by the U.S. FDA]
A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer Read more about A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer
MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer Read more about MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Read more about Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer Read more about Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer
Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer Read more about Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer